284 related articles for article (PubMed ID: 32638035)
1. The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls.
Lochner C; Chamberlain SR; Kidd M; Taljaard L; Fineberg NA; Robbins TW; Stein DJ
Psychopharmacology (Berl); 2020 Oct; 237(10):3117-3123. PubMed ID: 32638035
[TBL] [Abstract][Full Text] [Related]
2. Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder.
Lochner C; Chamberlain SR; Kidd M; Fineberg NA; Stein DJ
Psychopharmacology (Berl); 2016 Mar; 233(5):883-91. PubMed ID: 26645225
[TBL] [Abstract][Full Text] [Related]
3. Impaired planning in patients with obsessive-compulsive disorder and unaffected first-degree relatives: Evidence for a cognitive endophenotype.
Bey K; Kaufmann C; Lennertz L; Riesel A; Klawohn J; Heinzel S; Grützmann R; Kathmann N; Wagner M
J Anxiety Disord; 2018 Jun; 57():24-30. PubMed ID: 29890378
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder.
Lochner C; Simmons C; Kidd M; Chamberlain SR; Fineberg NA; van Honk J; Ipser J; Stein DJ
Behav Brain Res; 2012 Jan; 226(1):274-80. PubMed ID: 21963422
[TBL] [Abstract][Full Text] [Related]
5. Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype.
Cavedini P; Zorzi C; Piccinni M; Cavallini MC; Bellodi L
Biol Psychiatry; 2010 Jun; 67(12):1178-84. PubMed ID: 20381015
[TBL] [Abstract][Full Text] [Related]
6. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder.
Delorme R; Goussé V; Roy I; Trandafir A; Mathieu F; Mouren-Siméoni MC; Betancur C; Leboyer M
Eur Psychiatry; 2007 Jan; 22(1):32-8. PubMed ID: 17127035
[TBL] [Abstract][Full Text] [Related]
7. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
[TBL] [Abstract][Full Text] [Related]
8. Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.
Rutrick D; Stein DJ; Subramanian G; Smith B; Fava M; Hasler G; Cha JH; Gasparini F; Donchev T; Ocwieja M; Johns D; Gomez-Mancilla B
Adv Ther; 2017 Feb; 34(2):524-541. PubMed ID: 28044255
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
Wolmarans de W; Brand L; Stein DJ; Harvey BH
Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
[TBL] [Abstract][Full Text] [Related]
10. The effects of selective serotonin reuptake inhibitors on brain functional networks during goal-directed planning in obsessive-compulsive disorder.
Kim M; Jung WH; Shim G; Kwon JS
Sci Rep; 2020 Nov; 10(1):20619. PubMed ID: 33244182
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
12. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
[TBL] [Abstract][Full Text] [Related]
13. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).
Soomro GM; Altman D; Rajagopal S; Oakley-Browne M
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001765. PubMed ID: 18253995
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
16. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological dysfunction in adults with early-onset obsessive-compulsive disorder: the search for a cognitive endophenotype.
Zhang J; Yang X; Yang Q
Braz J Psychiatry; 2015; 37(2):126-32. PubMed ID: 25806473
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
19. Error-related brain activity as a transdiagnostic endophenotype for obsessive-compulsive disorder, anxiety and substance use disorder.
Riesel A; Klawohn J; Grützmann R; Kaufmann C; Heinzel S; Bey K; Lennertz L; Wagner M; Kathmann N
Psychol Med; 2019 May; 49(7):1207-1217. PubMed ID: 30744714
[TBL] [Abstract][Full Text] [Related]
20. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
Pallanti S; Quercioli L; Koran LM
J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
